GSK180
GSK180 is a selective, competitive, and potent inhibitor of kynurenine-3-monooxygenase (KMO), a key enzyme of tryptophan metabolism (IC50, ~6 nM), but shows negligible activity against other enzymes on the tryptophan pathway. GSK180 rapidly changes levels of kynurenine pathway metabolites, and acts as a useful tool to probe the therapeutic potential of KMO inhibition[1].
Product Specifications
CAS Number
[1799725-26-0]
UNSPSC
12352005
Target
KMO
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gsk180.html
Concentration
10mM
Purity
98.34
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)CCN1C(OC2=CC(Cl)=C(Cl)C=C12)=O
Molecular Formula
C10H7Cl2NO4
Molecular Weight
276.07
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Tumor Necrosis Factor Receptor 2, p75/p80 (TNFR 2, TNFRII, CD120b, Etanercept, p75, p75TNFR, p80 TNF alpha Receptor, Soluble TNFR1B Variant 1, TNFR75, TNFR80, Tumor Necrosis Factor beta Receptor, TNFBR, Tumor Necrosis Factor Binding Protein 2, TBP2, TBPII, Tumor Necrosis Factor Receptor Superfamily Member 1B Precursor, TNFRSF1B, TNR1B) (MaxLight 490) discontinued